We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Industry

AI Outperforms Pathologists in Diagnosing Breast Cancer

A study comparing the ability of Artificial Intelligence (AI) algorithms with expert pathologists in detecting metastatic breast cancer in whole-slide images found that the machine learning outperformed the pathologists. The results of the study published in the Journal of the American Medical Association suggests that deep learning algorithms have the ability to improve diagnosis and could be used to help clinicians detect cancer in the clinic. More...
20 Dec 2017

Siemens Healthineers Acquires Fast Track Diagnostics

Siemens Healthineers has entered into an agreement to acquire Fast Track Diagnostics, which supplies diagnostics tests that can distinguish between viral, bacterial, or other infections in one test. More...
18 Dec 2017
Image: Google has announced the open source release of DeepVariant, a deep learning technology to reconstruct the true genome sequence from HTS data with significantly greater accuracy than previous classical methods (Photo courtesy of Google).

Google Releases AI Tool for Precision Medicine

Google LLC has announced the open source release of DeepVariant, a deep learning technology to reconstruct the true genome sequence from high-throughput sequencing (HTS) data with significantly greater accuracy than previous classical methods. DeepVariant, which was developed after more than two years of research by the Google Brain team, in collaboration with Verily Life Sciences, transforms the task of variant calling, as this reconstruction problem is known in genomics, into an image classification problem well-suited to Google's existing technology and expertise. Within a year of its development, the deep learning model had won the 2016 PrecisionFDA Truth Challenge award for Highest SNP Performance, outperforming state-of-the-art methods. Since then, the Google Brain team has reduced the error rate by over 50%. More...
12 Dec 2017

GE Launches Drawbridge Health to Transform Blood Collection

GE Healthcare has introduced Drawbridge Health, a privately held healthcare technology company, which is developing a people-friendly system to integrate draw, collection and stabilize blood samples into a single device. The technology which integrates engineering and proprietary chemistries is also being developed to support room temperature shipping and streamlined downstream processing, thus ensuring reliable, accurate results. More...
05 Dec 2017

Laboratory-Developed Tests Market Driven by Cancer Treatment

The global market for laboratory-developed tests (LDTs) is estimated to be worth USD 13.2 billion and will grow by nearly 10% annually, driven mainly by oncology tests which will grow 60% faster than other types of LDTs. These are the latest findings of Kalorama Information, an independent medical market research firm. More...
28 Nov 2017

Global Lab Automation Market to Reach USD 5.20 Billion by 2022

The global lab automation market is expected to grow at a CAGR of 5.1% from USD 4.06 billion in 2017 to USD 5.20 billion by 2022, driven by process miniaturization, high demand in drug discovery and clinical diagnostics, higher reproducibility and accuracy, and a large workforce demand and supply gap. Additionally, enhanced productivity and reduced costs, better personnel safety, and small volumes of samples and reagents offered by lab automation are expected to further aid the market growth. However, the high cost of lab automation is limiting its adoption among small and medium-sized labs, which is expected to restrict the market growth. More...
28 Nov 2017
Image: The system-on-chip is designed to yield highly-secure molecular data, which can be used in the recognition and analysis of health threats caused by pathogens and other living organisms (Photo courtesy of Nano Global).

AI Chip to Help Capture and Analyze Molecular Data in RT

Molecular data company Nano Global is developing a chip using intellectual property (IP) from Arm Holdings, a semiconductor IP company, to help redefine how global health challenges ranging from superbugs to infectious diseases, and cancer are conquered. The pioneering system-on-chip (SoC) will yield highly-secure molecular data, which can be used in the recognition and analysis of health threats caused by pathogens and other living organisms. More...
28 Nov 2017
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Laboratory Software
ArtelWare


LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.